What is Ovarian PRP Treatment?
Ovarian PRP injection is an effective and safe technique, used to improve markers of Low Anti-Mullerian hormone (AMH) level which means the individual has low “ovarian reserve”.
PRP (Platelet Rich Plasma) is a type of injection therapy that can be used in numerous fertility treatments. With the help of PRP injections, it is possible to improve egg quantity/quality. PRP injections also let to improve uterine lining thickness.
Ovarian PRP treatment is performed to stimulate and produce new cellular growth with the help of an individual’s blood cells.
Ovarian PRP treatment is performed to stimulate and produce new cellular growth with the help of an individual’s blood cells.
How is Ovarian PRP Injection Done?
Ovarian PRP closely resembles the conventional PRP technique. First, the clinicians take a blood sample from the individuals. After, they place the blood into a device called a centrifuge. This device rapidly spins to separate platelets from the other components and produce a plasma that is rich in platelet.
This plasma that is rich in platelet is injected directly into the individual’s ovary. The procedure is done under anesthesia and takes around 2 hours. Ovarian PRP treatment is performed just after the menstrual bleeding. The individual can go back home after the Ovarian PRP treatment and may turn back to their daily activities the day after the procedure.
2 months after the ovarian PRP treatment, an AMH test is requested, and according to the doctor’s decision, IVF treatment starts.
Who is a Candidate for Ovarian PRP Treatment?
Not only the women with low anti-Mullerian hormone (AMH) levels but also the individuals who are suffering from unexplained infertility or the women who want to regain sexual drives naturally are ideal candidates for ovarian PRP treatment.
Ovarian PRP treatment may also be recommended to the individuals;
- Who has a hormonal deficiency or disordered hormonal balance,
- Who has a history of failed IVF treatments,
- Who has an ovarian failure,
- Who produces genetically abnormal embryos.
